Altea Therapeutics
closedAltea Therapeutics Corporation develops and commercializes transdermal drug delivery systems.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD19—28m (Dealroom.co estimates May 2009.)
Atlanta Georgia (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$17.0m | Series B | ||
$30.0m | Series C | ||
$32.8m | Series C | ||
N/A | $3.0m | Early VC | |
N/A | $685k | Debt | |
N/A | Acquisition | ||
Total Funding | AUD128m |